Abiopharma

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference

PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries